Live virus vaccines for monkeypox, COVID and smallpox are among the agents being developed at a new facility in the Dartmouth part of the New Bedford Business Park.
A pharmaceutical company is breaking ground Tuesday on a planned 45,000 square foot manufacturing facility in New Bedford that will be making vaccines for infectious diseases, including COVID-19.